Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status-Reference-Cited by-同舟云学术

Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status

Published:2017-01 Issue:1 Volume:71 Page:e12915
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Weeda Erin R.¹,Peacock W. Frank²,Fermann Gregory J.³,Baugh Christopher W.⁴,Wells Philip S.⁵,Ashton Veronica⁶,Crivera Concetta⁶,Wildgoose Peter⁶,Schein Jeff R.⁶,Coleman Craig I.¹

Affiliation:

1. University of Connecticut School of Pharmacy; Storrs CT USA

2. Department of Emergency Medicine; Baylor College of Medicine; Houston TX USA

3. Department of Emergency Medicine; University of Cincinnati; Cincinnati OH USA

4. Department of Emergency Medicine; Brigham & Women's Hospital; Boston MA USA

5. Thrombosis Program; Division of Hematology; Department of Medicine; University of Ottawa; Ottawa ON Canada

6. Janssen Scientific Affairs; LLC; Raritan NJ USA

Funder

Janssen Scientific Affairs, LLC, Raritan, NJ, USA

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12915/fullpdf

Reference16 articles.

1. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report;Kearon;Chest,2016

2. Centers for Medicare and Medicaid Services Chapter 6- Hospital Services Covered Under Part B. Report No.: 100-02, updated December, 2015 https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c06.pdf

3. Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism;van Bellen;Curr Med Res Opin,2014

4. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program;Bookhart;J Med Econ,2014

5. Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?;Laliberté;Curr Med Res Opin,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States;Clinical and Applied Thrombosis/Hemostasis;2018-11-15

2. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies;Current Medical Research and Opinion;2017-07-17